Celltrion Healthcare Co.
Scope
Date
~
-
Bio & Pharma
Celltrion’s Vegzelma listed on US PBM preferred drug list
South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare's Herzuma selected as funded brand in NZ
Celltrion Healthcare Co. announced on Thursday that its biosimilar anticancer drug Herzuma (active ingredient trastuzumab) for breast and gastr...
Dec 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion, Cyron to develop multi-specific antibody new drug
South Korea’s biopharmaceutical company Celltrion Inc. announced on Wednesday that it signed a joint research agreement with domestic startup ...
Dec 06, 2023 (Gmt+09:00)
-
Food & Beverage
Lotte Chilsung, E&J Gallo to jointly boost soju sale in US
South Korea’s Lotte Chilsung Beverage Co. announced on Tuesday that it partnered with the world's largest winery E&J Gallo to expand its...
Dec 05, 2023 (Gmt+09:00)
-
Fashion
Hyungji, Dishang Group to co-work for market development
South Korea’s Fashion Group Hyungji and China’s largest clothing exporter Dishang Group signed a memorandum of understanding (MOU) to te...
Dec 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare's Remsima SC to be launched in US in 2024
Celltrion Healthcare Co. announced on Thursday that its autoimmune disease treatment Zymfentra (the US product name for Remsima SC) is set to be lau...
Nov 30, 2023 (Gmt+09:00)
-
Executive reshuffles
Samsung sets up future business planning unit, keeps co-CEO system
Samsung Electronics Co., the world’s largest maker of memory chips and smartphones, is creating a new division tasked with working out future ...
Nov 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in Europe for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...
Nov 24, 2023 (Gmt+09:00)
-
Bio & Pharma
SK C&C to promote AI healthcare for brain diseases
South Korea's SK C&C announced on Thursday that it signed a strategic business agreement with Neurophet, a cloud-based AI platform for brain ima...
Nov 23, 2023 (Gmt+09:00)
-
Aerospace & Defense
S.Korean aerospace firms to co-work for SLV
South Korea's aerospace companies will collaborate to secure launch vehicle technology for small satellites weighing less than 500kg. The Sou...
Nov 21, 2023 (Gmt+09:00)
-
Hydrogen economy
Hanyang, Air Products to co-work for green ammonia
South Korea's Hanyang Corporation announced on Thursday it signed a memorandum of understanding (MOU) with the US industrial gas company Air Product...
Nov 16, 2023 (Gmt+09:00)
-
Asset management
Fed rate likely to be 2-4% over next decade: Oaktree's Howard Marks
Investors are experiencing the third “sea change,” facing the Federal Reserve’s rate hikes and its impact on economies and busines...
Nov 15, 2023 (Gmt+09:00)
-
The KED View
WeWork vs Starbucks as workspace in South Korea
In 2019, WeWork’s business model underwent a reality check.Its application for an initial public offering the same year was met with investor ...
Nov 14, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to supply Remsima to Brazil gov’t in three-year row
South Korea's Celltrion Healthcare Co. announced on Friday its autoimmune disease treatment Remsima (ingredient: infliximab) has won a bid for the B...
Nov 10, 2023 (Gmt+09:00)
-
Earnings
Celltrion enjoys record earnings on healthy biosimilar biz
South Korean pharmaceutical giant Celltrion Inc. logged record quarterly earnings on the strong performance of its key biosimilar products while exp...
Nov 07, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
Neowiz, SK Hynix to team up for global marketing
South Korean game developer Neowiz announced on Friday it has signed a memorandum of understanding (MOU) with SK Hynix Inc. for global marketing col...
Nov 03, 2023 (Gmt+09:00)
-
Leadership & Management
Ex-Kumho Petrochemical chair returns as Kumho Mitsui co-CEO
Park Chan-koo, former chairman of South Korea’s Kumho Petrochemical Group, has returned to the top position of Kumho Mitsui Chemicals Inc. as ...
Nov 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Naver-invested ichrogene enters Thai market
South Korea's digital healthcare startup ichrogene, with investment from Naver D2 Startup Factory (D2SF), entered into Thai market. Naver Corp....
Nov 01, 2023 (Gmt+09:00)
-
Carbon neutrality
SK Innovation, ENEOS to co-work for low-carbon energy
SK Innovation Co. said on Wednesday it will bolster its alliance with Japan's largest petroleum refiner ENEOS. This decision builds on their histor...
Nov 01, 2023 (Gmt+09:00)
-
Chemical Industry
S.Korea's SKC to sell fine ceramic business for $270 mn
South Korea's SKC Ltd. announced on Tuesday it will sell the fine ceramics business of its subsidiary SK enpulse, a semiconductor materials investme...
Oct 31, 2023 (Gmt+09:00)
-
E-commerce
SK Square in talks with Qoo10 for joint management of 11Street
SK Square Co., the investment management arm of SK Group, is in talks with Qoo10 Pte. to merge its e-commerce subsidiary 11Street with the Singapore...
Oct 27, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
LG Elec to launch new business with startup: LG NOVA head
SAN FRANCISCO – LG Electronics Inc. will set up a new business entity focusing on some of its new growth pillars — digital healthcare, c...
Oct 26, 2023 (Gmt+09:00)
-
Artificial intelligence
Lunit joins Saudi gov't healthcare sandbox
South Korea's medical AI company Lunit has joined the Saudi Arabian government's Healthcare Sandbox initiative, a move to advance digital transforma...
Oct 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics partners with Europe's largest VC
Samsung Biologics Co., the world's largest contract drug manufacturer, announced on Tuesday it has teamed up with global biotech venture capitalist ...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s approved merger removes hurdle to three-way combination
South Korea’s biosimilar drugmaker Celltrion group on Monday moved one step closer to the planned combination of its three major affiliates wi...
Oct 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets FDA approval for Remsima SC
South Korea's Celltrion Inc. announced on Monday it received a new drug approval for an autoimmune disease treatment Remsima SC (active ingredient i...
Oct 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare wins Remsima order in France, Italy
South Korea's Celltrion Healthcare Co. announced on Wednesday its autoimmune disease treatment Remsima (ingredient: infliximab) has won a bid for ho...
Oct 18, 2023 (Gmt+09:00)
-
Chemical Industry
SK Chemicals, Estée Lauder to co-work for eco-friendly packaging
South Korea's SK Chemicals Co. announced on Tuesday a partnership with Estée Lauder, the leading global cosmetics brand, to integrate circula...
Oct 17, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare to supply Yuflyma to US pharmacy chain
South Korea's Celltrion Healthcare Co. has inked a deal with the US specialty pharmacy chain CarePartners Pharmacy to supply its autoimmune disease ...
Oct 16, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's DuChemBio localizes core materials of radiopharmaceuticals
South Korea's DuChemBio Co. announced on Thursday that it has obtained final approval for a recovery and purification facility for oxygen-18 concent...
Oct 12, 2023 (Gmt+09:00)
Latest News
- 1 BMW surpasses Mercedes in Korean sales amid imported car market shake-up
- 2 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 3 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 4 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 5 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google